News

Lung cancer is the number one cause of cancer-related death in the United States—and diagnosing the disease early is critical in improving survival rates.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

As a family medicine physician, Dr. Mathis specializes in providing quality care for men, women, and children of all ages.

VFW Magazine talked to Dr. Todd Fristo about how the flu vaccine can prevent serious illness.

Survival rates for Black women are far worse after bystander CPR than for white men, according to a study published this month.

USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.

Dr. Mathis is accepting new patients of all ages and has special interests in pediatrics, women’s health, in-office procedures, and sports medicine.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Mikhail Kosiborod presented on the benefits of a cardiometabolic center of excellence for patients with cardiometabolic diseases at the ADA conference in San Diego.